AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Jul 9, 2015
29828_dirs_2015-07-09_501901de-3036-482d-a93b-354a35cb13b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-07-07
Reporting Person: MILLIGAN JOHN F (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-07 | Common Stock | M | 100000 | $14.5025 | Acquired | 1129108 | Direct |
| 2015-07-07 | Common Stock | S | 51665 | $113.6504 | Disposed | 1077443 | Direct |
| 2015-07-07 | Common Stock | S | 22720 | $114.7618 | Disposed | 1054723 | Direct |
| 2015-07-07 | Common Stock | S | 25315 | $115.7427 | Disposed | 1029408 | Direct |
| 2015-07-07 | Common Stock | S | 300 | $116.3833 | Disposed | 1029108 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-07 | Non-Qualified Stock Option (right to buy) | $14.5025 | M | 100000 | Disposed | 2016-01-25 | Common Stock (100000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $113.19 to $114.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $114.23 to $115.22. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $115.24 to $116.20. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $116.35 to $116.40. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.